http://orcid.org/0000-0003-4952-9637
References
- Norwitz ER, Edusa V, Park JS. Maternal physiology and complications of multiple pregnancy. Semin Perinatol. 2005;29:338–348.
- Sterrenburg MD, Veltman-Verhulst SM, Eijkemans MJ, et al. Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis. Hum Reprod Update. 2011;17:184–196.
- Patrizio P, Sakkas D. From oocyte to baby: a clinical evaluation of the biological efficiency of in vitro fertilization. Fertil Steril. 2009;91:1061–1066.
- Guerif F, Le Gouge A, Giraudeau B, et al. Limited value of morphological assessment at days 1 and 2 to predict blastocyst development potential: a prospective study based on 4042 embryos. Hum Reprod. 2007;22:1973–1981.
- Assou S, Gala A, Al-Edani T, et al. Non-invasive test for embryo competent selection by quantification of cell-free nucleic acids in embryo culture micro drop. Fertil Steril. 2014;102:e215.
- Capalbo A, Ubaldi FM, Cimadomo D, et al. MicroRNAs in spent blastocyst culture medium are derived from trophectoderm cells and can be explored for human embryo reproductive competence assessment. Fertil Steril. 2016;105:225–235.e1–3.
- Fragouli E, Ravichandran K, Munne S, et al. Clinical implications of mitochondrial DNA quantification on pregnancy outcomes: a blinded prospective non-selection study. Paper presented at: 32nd Annual Meeting of the European Society of Human Reproduction and Embryology; 2016; Helsinki, Finland.
- Tan TC, Ritter LJ, Whitty A, et al. Gray level co-occurrence matrices (GLCM) to assess microstructural and textural changes in pre-implantation embryos. Mol Reprod Dev. 2016;83:701–713.
- Ledee N, Gridelet V, Ravet S, et al. Impact of follicular G-CSF quantification on subsequent embryo transfer decisions: a proof of concept study. Hum Reprod. 2013;28:406–413.
- Ledee N, Lombroso R, Lombardelli L, et al. Cytokines and chemokines in follicular fluids and potential of the corresponding embryo: the role of granulocyte colony-stimulating factor. Hum Reprod. 2008;23:2001–2009.
- Herrler A, von Rango U, Beier HM. Embryo-maternal signalling: how the embryo starts talking to its mother to accomplish implantation. Reprod Biomed Online. 2003;6:244–256.
- Rutella S, Zavala F, Danese S, et al. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J Immunol. 2005;175:7085–7091.
- Munne S, Velilla E, Colls P, et al. Self-correction of chromosomally abnormal embryos in culture and implications for stem cell production. Fertil Steril. 2005;84:1328–1334.
- Ledee N, Munaut C, Serazin V, et al. Performance evaluation of microbead and ELISA assays for follicular G-CSF: a non-invasive biomarker of oocyte developmental competence for embryo implantation. J Reprod Immunol. 2010;86:126–132.
- Somers F, McHugh J. Performance verification of the Diafert® granulocyte colony-stimulating factor immunoassay. Proceedings of the 24th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI); Nov 10–13; Amsterdam, The Netherlands; 2016.
- Tournaye H, D’Hooghe T, Verheyen G, et al. Clinical performance of Diafert® to determine granulocyte colony stimulating factor concentration in follicular fluid as a predictor of implantation during in vitro fertilization. Proceedings of the 24th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI); 2016 Nov 10–13; Amsterdam, The Netherlands; 2016.
- Karpinski, K F, Hayward, S, Tryphonas, H.Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA). J Immunol Methods. 1987;103:189–194.